Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL443709 | 0.95 | THRB (0.44) | THRBTSHRALDH1A1TP53CYP3A4 | |
| SCHEMBL2511404 | 0.93 | THRB (0.43) | THRBTSHRALDH1A1TP53CYP3A4 | |
| SCHEMBL30451 | 0.91 | THRB (0.44) | THRBTSHRALDH1A1TP53CYP3A4 | |
| SCHEMBL2764467 | 0.91 | THRB (0.44) | THRBTSHRALDH1A1TP53CYP3A4 | |
| SCHEMBL28215329 | 0.91 | THRB (0.44) | THRBTSHRALDH1A1 | |
| SCHEMBL2637971 | 0.89 | THRB (0.43) | THRBTSHRALDH1A1TP53CYP3A4 | |
| SCHEMBL5446418 | 0.89 | THRB (0.43) | THRBTSHRALDH1A1TP53CYP3A4 | |
| SCHEMBL5264945 | 0.89 | THRB (0.43) | THRBTSHRALDH1A1TP53CYP3A4 | |
| SCHEMBL3756979 | 0.89 | THRB (0.43) | THRBTSHRALDH1A1TP53CYP3A4 | |
| SCHEMBL18045660 | 0.88 | THRB (0.43) | THRBTSHRALDH1A1TP53CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6676795-B1 | CURING MIXTURE CONTAINING (METH)ACRYLATE CAPPED POLYURETHANE, (METH)ACRYLATE DILUENT MONOMER, ANAEROBIC CURING SYSTEM AND FREE-RADICAL PHOTOINITIATOR | HENKEL LOCTITE CORPORATION | 2004-01-13 | — | — | US | claimed |
| US-8445615-B2 | Two-component adhesive suitable for construction purposes, its use and the cured structural bonds obtained thereby | HILTI AKTIENGESELLSCHAFT (LI) | 2013-05-21 | — | — | US | disclosed |
| US-20130085186-A1 | COSMETIC PREPARATIONS BASED ON MOLECULARLY IMPRINTED POLYMERS | BASF SE (DE) | 2013-04-04 | — | — | US | disclosed |
| EP-2336214-B1 | A two-component adhesive suitable for construction purposes, its use and the cured structural bonds obtained thereby | HILTI AG (LI) | 2012-05-02 | — | — | EP | disclosed |
| EP-2336214-A1 | A two-component adhesive suitable for construction purposes, its use and the cured structural bonds obtained thereby | HILTI Aktiengesellschaft (LI) | 2011-06-22 | — | — | EP | disclosed |
| US-20110143061-A1 | TWO-COMPONENT ADHESIVE SUITABLE FOR CONSTRUCTION PURPOSES, ITS USE AND THE CURED STRUCTURAL BONDS OBTAINED THEREBY | HILTI AKTIENGESELLSCHAFT (LI) | 2011-06-16 | — | — | US | disclosed |
| US-6676795-B1 | CURING MIXTURE CONTAINING (METH)ACRYLATE CAPPED POLYURETHANE, (METH)ACRYLATE DILUENT MONOMER, ANAEROBIC CURING SYSTEM AND FREE-RADICAL PHOTOINITIATOR | HENKEL LOCTITE CORPORATION | 2004-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130085186-A1 | COSMETIC PREPARATIONS BASED ON MOLECULARLY IMPRINTED POLYMERS | PRDM7, FABP4, PLIN1 | THRB 4662/4885TSHR 4219/4885ALDH1A1 166/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.